CRPC

Oncology

91 drugs in development·37 companies·1 clinical trial

Drug Pipeline by Phase

Approved(9)

Drug	Company
abiraterone	Aptinyx Inc. (APTX)
abiraterone	Mersana Therapeutics, Inc. (MRSN)
abiraterone	DR REDDYS LABORATORIES LTD (RDY)
abiraterone	Mylan II B.V. (MYL)
apalutamide	Greenwich LifeSciences, Inc. (GLSI)
docetaxel	PFIZER INC (PFE)
enzalutamide	Aptinyx Inc. (APTX)
enzalutamide	X4 Pharmaceuticals, Inc (XFOR)
yonsa	SUNSET ISLAND GROUP (SUN)

Phase 3(22)

Drug	Company
177lu-pnt2002	POINT Biopharma Global Inc. (PNT)
177lu-psma-617	ENDOCYTE INC (ECYT)
68ga-psma-11	Novartis AG (NVS)
68Ga-PSMA-11	Novartis AG (NVS)
Abiraterone acetate	Merck & Co., Inc. (MRK)
ardt	Novartis AG (NVS)
ARDT	Novartis AG (NVS)
Cabazitaxel 60 mg Solution for Injection	KYNTRA BIO INC. (KYNB)
Ciprofloxacin 500g	UNITED THERAPEUTICS Corp (UTHR)
Enzalutamide	Merck & Co., Inc. (MRK)
Fludrocortisone acetate	Merck & Co., Inc. (MRK)
Hydrocortisone	Merck & Co., Inc. (MRK)
Hydrocortisone	Merus N.V. (MRUS)
Opevesostat	Merus N.V. (MRUS)
Opevesostat	Merck & Co., Inc. (MRK)
pf-06821497	PFIZER INC (PFE)
pnt2002	POINT Biopharma Global Inc. (PNT)
PNT2002	Lantheus Holdings, Inc. (LNTH)
Radium Chloride Ra-223	KYNTRA BIO INC. (KYNB)
regn15505	REGENERON PHARMACEUTICALS, INC. (REGN)
Talazoparib with enzalutamide	PFIZER INC (PFE)
Xaluritamig	Xencor Inc (XNCR)

Phase 2(12)

Drug	Company
aaa617	Novartis AG (NVS)
adxs-psa	OLD AYALA, INC (AYLA)
ADXS-PSA	Ayala Pharmaceuticals, Inc. (ADXS)
Enzalutamide	Novartis AG (NVS)
Enzalutamide	UNITED THERAPEUTICS Corp (UTHR)
FG-3180	KYNTRA BIO INC. (KYNB)
induction therapy	Novartis AG (NVS)
JSB462	Novartis AG (NVS)
lp-100	Lantern Pharma Inc. (LTRN)
Metronidazole	UNITED THERAPEUTICS Corp (UTHR)
ODM-201	KYNTRA BIO INC. (KYNB)
ZEN003694	KYNTRA BIO INC. (KYNB)

Phase 1(22)

Drug	Company
[177lu]lu-psma-617	Novartis AG (NVS)
[177Lu]Lu-PSMA-617	Novartis AG (NVS)
[68ga]ga-nns309	Novartis AG (NVS)
[68ga]ga-psma-11	Novartis AG (NVS)
68ga-nns309	Novartis AG (NVS)
adi-212	Adicet Bio, Inc. (ACET)
androgen deprivation therapy	NOVARTIS AG (NVSEF)
androgen deprivation therapy	Novartis AG (NVS)
arx517	Ambrx Biopharma Cayman, Inc. (AMAM)
ec1169	ENDOCYTE INC (ECYT)
hsk46575	SPRING PHARMACEUTICAL GROUP, INC. (CYIG)
inr731	NOVARTIS AG (NVSEF)
inr731	Novartis AG (NVS)
jsb462	Novartis AG (NVS)
mervometostat	PFIZER INC (PFE)
onct-534	Oncternal Therapeutics, Inc. (ONCT)
Relacorilant	KYNTRA BIO INC. (KYNB)
rinzimetostat	Oric Pharmaceuticals, Inc. (ORIC)
Tinengotinib	ARS Pharmaceuticals, Inc. (SPRY)
Tinengotinib	Royalty Pharma plc (RPRX)
Tinengotinib	Janux Therapeutics, Inc. (JANX)
Tinengotinib	Myovant Sciences Ltd. (MYOV)

Preclinical(4)

Drug	Company
225ac-psma-62	POINT Biopharma Global Inc. (PNT)
ATNM-400	Actinium Pharmaceuticals, Inc. (ATNM)
p-psma-allo1	Poseida Therapeutics, Inc. (PSTX)
psma x cd28 tracir	Janux Therapeutics, Inc. (JANX)

Phase 1/Phase 2(14)

Drug	Company
[68ga]ga-neob	Novartis AG (NVS)
177lu-betabart	Radiopharm Theranostics Limited (RADX)
68ga-fap-2286	Novartis AG (NVS)
abiraterone	Novartis AG (NVS)
abiraterone	CONSTELLATION PHARMACEUTICALS INC (CNST)
abiraterone	VERTEX PHARMACEUTICALS INC / MA (VRTX)
Abiraterone	Novartis AG (NVS)
amo959	Novartis AG (NVS)
AMO959	Novartis AG (NVS)
cpi-1205	VERTEX PHARMACEUTICALS INC / MA (VRTX)
cpi-1205	CONSTELLATION PHARMACEUTICALS INC (CNST)
ft-7051	Forma Therapeutics Holdings, Inc. (FMTX)
regn15505+regn4336	REGENERON PHARMACEUTICALS, INC. (REGN)
SX-682	UNITED THERAPEUTICS Corp (UTHR)

Phase 4(8)

Drug	Company
AAA617	Novartis AG (NVS)
Abiraterone Oral Tablet	KYNTRA BIO INC. (KYNB)
Apalutamide	UNITED THERAPEUTICS Corp (UTHR)
Enzalutamide Oral Capsule	KYNTRA BIO INC. (KYNB)
Lu-17-PSMA-617	Novartis AG (NVS)
Memantine Hydrochloride	KYNTRA BIO INC. (KYNB)
NAH therapy	KYNTRA BIO INC. (KYNB)
Radium-223 dichloride	KYNTRA BIO INC. (KYNB)

BioSniper tracks 91 drugs in development for CRPC across 37 companies.

There are 1 clinical trial targeting CRPC tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.